106 related articles for article (PubMed ID: 21695460)
1. SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.
Collie-Duguid ES; Sweeney K; Stewart KN; Miller ID; Smyth E; Heys SD
Breast Cancer Res Treat; 2012 Apr; 132(3):807-18. PubMed ID: 21695460
[TBL] [Abstract][Full Text] [Related]
2. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.
Abdel-Fatah TMA; Agarwal D; Liu DX; Russell R; Rueda OM; Liu K; Xu B; Moseley PM; Green AR; Pockley AG; Rees RC; Caldas C; Ellis IO; Ball GR; Chan SYT
Lancet Oncol; 2016 Jul; 17(7):1004-1018. PubMed ID: 27312051
[TBL] [Abstract][Full Text] [Related]
3. CD10 expression as a potential predictor of pathological complete response in ER-negative and triple-negative breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.
Dimitrov G; Shousha S; Troianova P
Exp Mol Pathol; 2024 Feb; 135():104885. PubMed ID: 38281565
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Esserman LJ; Berry DA; Cheang MC; Yau C; Perou CM; Carey L; DeMichele A; Gray JW; Conway-Dorsey K; Lenburg ME; Buxton MB; Davis SE; van't Veer LJ; Hudis C; Chin K; Wolf D; Krontiras H; Montgomery L; Tripathy D; Lehman C; Liu MC; Olopade OI; Rugo HS; Carpenter JT; Livasy C; Dressler L; Chhieng D; Singh B; Mies C; Rabban J; Chen YY; Giri D; Au A; Hylton N;
Breast Cancer Res Treat; 2012 Apr; 132(3):1049-62. PubMed ID: 22198468
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.
Nadin SB; Sottile ML; Montt-Guevara MM; Gauna GV; Daguerre P; Leuzzi M; Gago FE; Ibarra J; Cuello-Carrión FD; Ciocca DR; Vargas-Roig LM
Cell Stress Chaperones; 2014 Jul; 19(4):493-505. PubMed ID: 24307543
[TBL] [Abstract][Full Text] [Related]
6. Outcome after neoadjuvant chemotherapy in Asian breast cancer patients.
Lim LY; Miao H; Lim JS; Lee SC; Bhoo-Pathy N; Yip CH; Taib NA; Chan P; Tan EY; Lim SH; Lim GH; Woo E; Tan YS; Lee JA; Wong M; Tan PH; Ong KW; Wong FY; Yap YS; Hartman M
Cancer Med; 2017 Jan; 6(1):173-185. PubMed ID: 28000426
[TBL] [Abstract][Full Text] [Related]
7. The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients.
Fagerholm R; Schmidt MK; Khan S; Rafiq S; Tapper W; Aittomäki K; Greco D; Heikkinen T; Muranen TA; Fasching PA; Janni W; Weinshilboum R; Loehberg CR; Hopper JL; Southey MC; Keeman R; Lindblom A; Margolin S; Mannermaa A; Kataja V; Chenevix-Trench G; ; Lambrechts D; Wildiers H; Chang-Claude J; Seibold P; Couch FJ; Olson JE; Andrulis IL; Knight JA; García-Closas M; Figueroa J; Hooning MJ; Jager A; Shah M; Perkins BJ; Luben R; Hamann U; Kabisch M; Czene K; Hall P; Easton DF; Pharoah PD; Liu J; Eccles D; Blomqvist C; Nevanlinna H
Oncotarget; 2015 Apr; 6(10):7390-407. PubMed ID: 25823661
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.
Mayer EL; Carey LA; Burstein HJ
Breast Cancer Res; 2007; 9(5):110. PubMed ID: 17888189
[TBL] [Abstract][Full Text] [Related]
9. SerpinB3/B4: mediators of Ras-driven inflammation and oncogenesis.
Catanzaro JM; Sheshadri N; Zong WX
Cell Cycle; 2014; 13(20):3155-6. PubMed ID: 25485489
[No Abstract] [Full Text] [Related]
10. SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.
Gutiérrez-Chamorro L; Felip E; Castellà E; Quiroga V; Ezeonwumelu IJ; Angelats L; Esteve A; Perez-Roca L; Martínez-Cardús A; Fernandez PL; Ferrando-Díez A; Pous A; Bergamino M; Cirauqui B; Romeo M; Teruel I; Mesia R; Clotet B; Riveira-Muñoz E; Margelí M; Ballana E
Cell Oncol (Dordr); 2024 Feb; 47(1):189-208. PubMed ID: 37667113
[TBL] [Abstract][Full Text] [Related]
11. Expression of Polo-Like Kinase 4(PLK4) in Breast Cancer and Its Response to Taxane-Based Neoadjuvant Chemotherapy.
Li Z; Dai K; Wang C; Song Y; Gu F; Liu F; Fu L
J Cancer; 2016; 7(9):1125-32. PubMed ID: 27326256
[TBL] [Abstract][Full Text] [Related]
12. Identification of tumour regression in neoadjuvantly treated pancreatic cancer is based on divergent and nonspecific criteria.
Holm MB; Lenggenhager D; Detlefsen S; Sántha P; Verbeke CS
Histopathology; 2024 Apr; ():. PubMed ID: 38571446
[TBL] [Abstract][Full Text] [Related]
13. Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.
Derouane F; van Marcke C; Berlière M; Gerday A; Fellah L; Leconte I; Van Bockstal MR; Galant C; Corbet C; Duhoux FP
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010869
[TBL] [Abstract][Full Text] [Related]
14. An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients.
Moore LM; Wilkinson R; Altan M; Toki M; Carvajal-Hausdorf DE; McGuire J; Ehrlich BE; Rimm DL
NPJ Breast Cancer; 2018; 4():6. PubMed ID: 29560416
[TBL] [Abstract][Full Text] [Related]
15. Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca
Duong MQ; Gadet R; Treilleux I; Borel S; Nougarède A; Marcillat O; Gonzalo P; Mikaelian I; Popgeorgiev N; Rimokh R; Gillet G
Cell Death Dis; 2023 Jul; 14(6):392. PubMed ID: 37391438
[TBL] [Abstract][Full Text] [Related]
16. RETRACTED ARTICLE: The value of U-NGAL expression as a potential prognostic biomarker in patients with renal cancer after neoadjuvant chemotherapy with cisplatin.
Ebrahimi T; Pirasteh H; Rezakhaniha B; Dormanesh B; Rabati RG; Yahaghi E; Mokarizadeh A
Tumour Biol; 2015 Jun; ():. PubMed ID: 26109001
[No Abstract] [Full Text] [Related]
17. Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy.
Agrawal SK; Chatterjee S; Arun I; Ahmed R
Indian J Surg Oncol; 2017 Jun; 8(2):245-246. PubMed ID: 28546731
[No Abstract] [Full Text] [Related]
18. Squamous Cell Carcinoma Antigen-encoding Genes
Saidak Z; Morisse MC; Chatelain D; Sauzay C; Houessinon A; Guilain N; Soyez M; Chauffert B; Dakpé S; Galmiche A
Anticancer Res; 2018 Mar; 38(3):1343-1352. PubMed ID: 29491058
[TBL] [Abstract][Full Text] [Related]
19. SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.
Martini A; Prasai K; Zemla TJ; Ahmed FY; Elnagar MB; Giama NH; Guzzardo V; Biasiolo A; Fassan M; Yin J; Pontisso P; Roberts LR
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201652
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
